Subtopic Deep Dive
Genetics of Familial Vascular Malformations
Research Guide
What is Genetics of Familial Vascular Malformations?
Genetics of Familial Vascular Malformations studies hereditary mutations causing vascular anomalies like HHT (ENG/ACVRL1), CM-AVM (RASA1/EPHB4), and familial CCM (KRIT1/PDCD10/CCM2).
Key syndromes include capillary malformation-arteriovenous malformation (CM-AVM) from RASA1 mutations (Revençu et al., 2008, 423 citations) and EPHB4 mutations (Amyere et al., 2017, 278 citations). Hereditary hemorrhagic telangiectasia involves ENG and ACVRL1 genes, modeled in mice (Park et al., 2009, 298 citations). Over 10 major papers detail genotype-phenotype correlations and signaling pathways like RAS-MAPK.
Why It Matters
Genetic identification enables presymptomatic screening in families with RASA1 mutations, reducing AVM hemorrhage risk (Revençu et al., 2008). Insights into KRAS somatic mutations guide targeted therapies for brain AVMs (Nikolaev et al., 2018). Vikkula et al. (2021, 206 citations) highlight mTOR inhibitors for PIK3CA-related overgrowth, shifting care to preventive gene-based interventions.
Key Research Challenges
Genotype-Phenotype Correlation
Mapping specific mutations like RASA1 to multifocal AVM phenotypes varies across families (Revençu et al., 2008). EPHB4 loss deregulates RAS-MAPK differently from RASA1 (Amyere et al., 2017). Incomplete penetrance complicates screening protocols.
Somatic vs Germline Mutations
Distinguishing somatic KRAS activations in sporadic AVMs from germline RASA1 defects requires tissue sequencing (Nikolaev et al., 2018). Mouse models show flow-dependent AVMs in Alk1 mutants (Corti et al., 2011). Detection limits hinder clinical translation.
Therapeutic Targeting Pathways
RAS-MAPK and PI3K/AKT/mTOR pathways are mutated but lack specific inhibitors (Queisser et al., 2021). Endoglin absence causes AVMs via dysregulated angiogenesis (Mahmoud et al., 2010). Gene therapy trials face delivery challenges in vascular beds.
Essential Papers
Somatic Activating <i>KRAS</i> Mutations in Arteriovenous Malformations of the Brain
Sergey I. Nikolaev, Sandra Vetiska, Ximena Bonilla et al. · 2018 · New England Journal of Medicine · 439 citations
We identified activating KRAS mutations in the majority of tissue samples of arteriovenous malformations of the brain that we analyzed. We propose that these malformations develop as a result of KR...
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
Nicole Revençu, Laurence M. Boon, John B. Mulliken et al. · 2008 · Human Mutation · 423 citations
Capillary malformation-arteriovenous malformation (CM-AVM) is a newly recognized autosomal dominant disorder, caused by mutations in the RASA1 gene in six families. Here we report 42 novel RASA1 mu...
Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
Sung Ok Park, Mamta Wankhede, Young Jae Lee et al. · 2009 · Journal of Clinical Investigation · 298 citations
Arteriovenous malformations (AVMs) are vascular anomalies where arteries and veins are directly connected through a complex, tangled web of abnormal arteries and veins instead of a normal capillary...
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling
Mustapha Amyere, Nicole Revençu, Raphaël Helaers et al. · 2017 · Circulation · 278 citations
Background: Most arteriovenous malformations (AVMs) are localized and occur sporadically. However, they also can be multifocal in autosomal-dominant disorders, such as hereditary hemorrhagic telang...
Biology of Vascular Malformations of the Brain
Gabrielle G. Leblanc, Eugene V. Golanov, Issam A. Awad et al. · 2009 · Stroke · 266 citations
Background and Purpose— This review discusses recent research on the genetic, molecular, cellular, and developmental mechanisms underlying the etiology of vascular malformations of the brain (VMBs)...
Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin
Marwa Mahmoud, Kathleen R. Allinson, Zhenhua Zhai et al. · 2010 · Circulation Research · 251 citations
Rationale : Arteriovenous malformations (AVMs) result in anomalous direct blood flow between arteries and veins, bypassing the normal capillary bed. Depending on size and location, AVMs may lead to...
Genetic Basis and Therapies for Vascular Anomalies
Angela Queisser, Emmanuel Seront, Laurence M. Boon et al. · 2021 · Circulation Research · 206 citations
Vascular and lymphatic malformations represent a challenge for clinicians. The identification of inherited and somatic mutations in important signaling pathways, including the PI3K (phosphoinositid...
Reading Guide
Foundational Papers
Start with Revençu et al. (2008, 423 citations) for RASA1/CM-AVM definition; Park et al. (2009, 298 citations) for HHT mouse AVM imaging; Leblanc et al. (2009, 266 citations) for brain VMB biology overview.
Recent Advances
Nikolaev et al. (2018, 439 citations) on KRAS in brain AVMs; Amyere et al. (2017, 278 citations) on EPHB4/CM-AVM2; Queisser et al. (2021, 206 citations) on genetic therapies.
Core Methods
Germline sequencing (Revençu et al., 2008); real-time imaging in Alk1 mutants (Park et al., 2009; Corti et al., 2011); pathway analysis for RAS-MAPK/PI3K (Nikolaev et al., 2018; Queisser et al., 2021).
How PapersFlow Helps You Research Genetics of Familial Vascular Malformations
Discover & Search
Research Agent uses searchPapers and exaSearch to find RASA1 mutation papers like Revençu et al. (2008), then citationGraph reveals 423 citing works on CM-AVM. findSimilarPapers expands to EPHB4 studies (Amyere et al., 2017).
Analyze & Verify
Analysis Agent applies readPaperContent to extract KRAS mutation frequencies from Nikolaev et al. (2018), verifies claims with CoVe chain-of-verification, and runPythonAnalysis computes signaling pathway statistics across 10 papers using pandas for GRADE evidence grading.
Synthesize & Write
Synthesis Agent detects gaps in PI3K therapies (Queisser et al., 2021), flags RAS-MAPK contradictions between germline/somatic models. Writing Agent uses latexEditText, latexSyncCitations for genotype tables, latexCompile for review drafts, exportMermaid for AVM signaling diagrams.
Use Cases
"Analyze mutation frequencies in RASA1 papers for familial AVM risk models."
Research Agent → searchPapers('RASA1 familial AVM') → Analysis Agent → runPythonAnalysis (pandas frequency table from 5 abstracts) → CSV export of penetrance stats.
"Draft LaTeX review on ENG/ACVRL1 HHT genetics with citations."
Synthesis Agent → gap detection (Park et al., 2009) → Writing Agent → latexEditText (intro section) → latexSyncCitations (10 papers) → latexCompile (PDF review).
"Find code for AVM mouse model simulations from genetics papers."
Research Agent → paperExtractUrls (Corti et al., 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect (flow simulation scripts) → Python sandbox test.
Automated Workflows
Deep Research workflow scans 50+ papers on RASA1/EPHB4 via searchPapers → citationGraph → structured report on mutation spectra. DeepScan applies 7-step CoVe to verify KRAS somatic rates (Nikolaev et al., 2018) with GRADE scoring. Theorizer generates hypotheses linking ALK1 flow interactions to gene therapies (Corti et al., 2011).
Frequently Asked Questions
What defines Genetics of Familial Vascular Malformations?
Study of germline mutations in genes like RASA1, EPHB4, ENG causing hereditary AVM syndromes such as CM-AVM and HHT (Revençu et al., 2008; Amyere et al., 2017).
What are key methods in this subtopic?
Whole-exome sequencing identifies germline variants; mouse models image de novo AVMs (Park et al., 2009); RAS-MAPK pathway assays test mutation effects (Nikolaev et al., 2018).
What are major papers?
Revençu et al. (2008, 423 citations) on RASA1 in CM-AVM; Nikolaev et al. (2018, 439 citations) on somatic KRAS; Queisser et al. (2021, 206 citations) on therapies.
What open problems exist?
Incomplete penetrance in RASA1 families; somatic-germline distinction in AVMs; targeted therapies for RAS-MAPK/PI3K pathways (Amyere et al., 2017; Queisser et al., 2021).
Research Vascular Malformations Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genetics of Familial Vascular Malformations with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers